Greenstone makes two executive appointments

PEAPACK, N.J. The generics subsidiary of the world’s biggest drug maker has made two new executive appointments.

Greenstone, a subsidiary of Pfizer that makes generic and authorized generic drugs, announced the appointment of Christine Versichele, as director of U.S. generic channel strategies, and Mark Mancinotti, as national account director.

Versichele, whom the company called a “long-term generic industry professional,” has worked in the pharmaceutical industry for 25 years, mostly in generics. Mancinotti has also worked in the industry for 25 years, mostly in national and regional account management.

In their new positions, Versichele and Mancinotti will be responsible for create sales and policy initiatives for the company.